Dr. Siraj Khan

Assistant Professor

siraj.khan@cust.edu.pk

PROFILE SUMMARY

Dr. Siraj Khan completed his Ph.D. in Pharmacy (Pharmaceutical Chemistry) obtained through the HEC Indigenous PhD Fellowship Program at Quaid-i-Azam University, Islamabad, Pakistan. He has more than 5-year of research and teaching experience nationally and internationally and has held various positions including Research associate, Lecturer and Assistant Professor. His area of research is medicinal chemistry focusses on multi-step organic and inorganic synthesis, molecular modeling, and various in vitro biological activities. In addition, he has extensive experience in using advanced analytical techniques. He had to work on research project at College of Pharmacy, Institute for Therapeutics Discovery and Development, University of Minnesota, USA and Inonu University, Malatya, Turkey. Dr. Khan actively contributes as a reviewer for various academic journals, ensuring the quality and advancement of research in his field. His dedication to academia and research reflects his strong commitment to advancing critical studies in medicinal chemistry.

QUALIFICATION
PhD	Pharmaceutical Chemistry	Quaid-I-Azam University, Islamabad, Pakistan	2023
M.Phil	Pharmacognosy	Quaid-I-Azam University, Islamabad, Pakistan	2017
Pharm-D	Pharmaceutical Sciences	Kohat University of Science and Technology,Kohat, Pakistan	2014

TEACHING EXPERIENCE
Assistant Professor	Capital University of Science and Technology (CUST), Islamabad	Since – 2024
Assistant Professor	CECOS University of IT and Emerging Sciences, Peshawar	Feb 2024 – Aug 2024
Assistant Professor	Cadson College of Pharmacy, Kharian,Punjab	2023 – 2024

RESEARCH AREAS / INTERESTS
1.	Medicinal chemistry
2.	Phytochemistry
3.	Organometallic chemistry
4.	Organic synthesis

SR.	JOURNAL PUBLICATIONS	YEAR
1	S. Ullah, S. U. H. Khan, T. Ali, M. T. Zeb, M. H. Riaz, S. Khan, and S. M. Goyal, “Molecular characterization and antibiotic susceptibility of Shiga toxin-producing Escherichia coli (STEC) isolated from raw milk of dairy bovines in Khyber Pakhtunkhwa, Pakistan,” PloS One, vol. 19, no. 9, pp. e0307830, 2024.	2024
2	A. Ahmed, P. A. Channar, S. A. Ejaz, A. Saeed, M. Saleem, T. Shamim, T. A. Wani, J. Hussain, N. Gul, S. Khan, S. Zargar, and L. Chen, “Synthesis of small size adamantane-linked aminothiazoles as potent inhibitors of urease, α-glucosidase and carbonic anhydrase and their molecular docking studies,” Chemical Papers, vol. 78, pp. 1–24, 2024.	2024
3	S. Khan, N. Bu˘gday, S¸. Ya¸sar, A. U. Rehman, I. U. Haq, and S. Ya¸sar, “Synthesis, biological evaluation and molecular docking studies of 8-(hetero) aryl caffeine derivatives,” Journal of Organometallic Chemistry, vol. 997, pp. 122794, 2023.	2023
4	S. Khan, M. U. Rehman, M. Z. I. Khan, R. Kousar, K. Muhammad, I. U. Haq, M. I. Khan, N. Almasoud, T. S. Alomar, and A. Rauf, “In vitro and in vivo antioxidant therapeutic evaluation of phytochemicals from different parts of Dodonaea viscosa Jacq.,” Frontiers in Chemistry, vol. 11, p. 1268949, 2023.	2023
5	M. Akko¸c, S. Khan, H. Y¨uce, N. B. T¨urkmen, S¸. Ya¸sar, S. Ya¸sar, and ˙I. Ozdemir, “Molecular docking and in vitro anticancer studies of silver (I)-N-heterocyclic carbene complexes,” Heliyon, vol. 8, no. 8, pp. e10133, 2022.	2022
6	N. Bu˘gday, S. Khan, S. Ya¸sar, F. Bulut, H. Boulebd, H. Karabıyık, E. Oz, A. U. Rehman, and ˙I. Ozdemir, “Pd-NHC complex catalyzed CH bond activation reactions of caffeine and 2-isobuthylthiazole,” Molecular Catalysis, vol. 530, p. 112590, 2022.	2022
7	O. Ekinci, M. Akkoc, S. Khan, S. Ya¸sar, C. G¨urses, S. Noma, S. Balcıo˘glu, B. Sen, M. Ayg¨un, and ˙I. Yılmaz, “Synthesis and biological evaluation of Au-NHC complexes,” Applied Organometallic Chemistry, vol. 36, no. 9, pp. e6811, 2022.	2022
8	S. Khan, N. Bu˘gday, A. U. Rehman, I. U. Haq, S. Ya¸sar, and ˙I. Ozdemir, “Synthesis, molecular docking, and biological evaluation of 5-alkyl (aryl)-2-isobutylthiazole derivatives: As α-amylase, α-glucosidase, and protein kinase inhibitors,” Applied Organometallic Chemistry, vol. 36, no. 5, pp. e6641, 2022.	2022
9	K. Muhammad, M. Saqlain, G. Muhammad, A. Hamdard, M. Naveed, M. H. Butt, S. Khan, N. S. Ismael, Z. Khan, and Y. Karatas, “Knowledge, attitude, and practices (KAPs) of community pharmacists regarding COVID-19: a cross-sectional survey in 2 provinces of Pakistan,” Disaster Medicine and Public Health Preparedness, vol. 16, no. 5, pp. 1864–1872, 2022.	2022
10	N. Bu˘gday, S. Khan, S. Ya¸sar, and ˙I. Ozdemir, “CH Bond activation of 2-isobutylthiazole at C5 position catalysed by Pd-N-heterocyclic carbene complexes,” Journal of Organometallic Chemistry, vol. 937, pp. 121730, 2021.	2021
11	S. Khan, N. Bu˘gday, S. Ya¸sar, N. Ullah, and ˙I. Ozdemir, “Pd-N-heterocyclic carbene complex catalysed C–H bond activation of 2-isobutylthiazole at the C5 position with aryl bromides,” New Journal of Chemistry, vol. 45, no. 14, pp. 6281–6292, 2021.	2021
12	Y. Hussain, K. Muhammad, M. F. Umar, A. Omerkhail, S. Khan, M. Kamran, H. Rashid, and Z. Khan, “COVID-19 in five neighboring limited resources countries: a financial and health threats,” Value in Health Regional Issues, vol. 24, pp. 114–116, 2021.	2021
13	S. Khan, Z. Khan, and Y. Karata¸s, “Adverse Drug Events and Surgical Patients: Need for Pharmacovigilance Urgency,” Hellenic Journal of Surgery, vol. 92, pp. 35–36, 2020.	2020
14	M. Kamran, R. Kousar, S. Ullah, S. Khan, M. F. Umer, H. U. Rashid, Z. Khan, M. I. Khan, and M. U. Rehman, “Taxonomic distribution of medicinal plants for Alzheimer’s Disease: a cue to novel drugs,” International Journal of Alzheimer’s Disease, vol. 01, p. 7603015, 2020.	2020

Our Team

Dr. Siraj Khan

PROFILE SUMMARY

Other Members